Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LYG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LUZP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC155 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU6F1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100287387 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CFAP97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM124A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP7-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEXM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCO3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on